These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 101294)

  • 21. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
    Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG
    Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CEA tissue staining in colorectal cancer patients. A way to improve the usefulness of serial serum CEA evaluation.
    Midiri G; Amanti C; Benedetti M; Campisi C; Santeusanio G; Castagna G; Peronace L; Di Tondo U; Di Paola M; Pascal RR
    Cancer; 1985 Jun; 55(11):2624-9. PubMed ID: 2986820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carcinoembryonic antigen in malignant and nonmalignant gynecologic tumors: circulating levels and tissue localization.
    Rutanen EM; Lindgren J; Sipponen P; Stenman UP; Saksela E; Seppäla M
    Cancer; 1978 Aug; 42(2):581-90. PubMed ID: 354771
    [No Abstract]   [Full Text] [Related]  

  • 24. Circulating tumor markers in the monitoring of gynecologic malignancies.
    Schwartz PE; Chambers SK; Chambers JT; Gutmann J; Katopodis N; Foemmel R
    Cancer; 1987 Aug; 60(3):353-61. PubMed ID: 3594371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of Plasma CEA and CEA tissue staining in poorly differentiated colorectal cancer.
    Goslin R; O'Brien MJ; Steele G; Mayer R; Wilson R; Corson JM; Zamcheck N
    Am J Med; 1981 Aug; 71(2):246-53. PubMed ID: 6167166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunohistochemical study of carcinoembryonic antigen of the tissue and cell levels in adenocarcinoma of the uterus].
    Suzuki M; Ohwada M; Tamada T; Shiina Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jun; 37(6):897-902. PubMed ID: 3894535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carcinoembryonic antigen in histopathology: immunoperoxidase staining of conventional tissue sections.
    Goldenberg DM; Sharkey RM; Primus FJ
    J Natl Cancer Inst; 1976 Jul; 57(1):11-22. PubMed ID: 794493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunosuppressive acidic protein in patients with gynecologic cancer.
    Sawada M; Okudaira Y; Matsui Y; Shimizu Y
    Cancer; 1984 Aug; 54(4):652-6. PubMed ID: 6744202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical localization of tumor markers in epithelial ovarian cancer.
    Casper S; van Nagell JR; Powell DF; Dubilier LD; Donaldson ES; Hanson MB; Pavlik EJ
    Am J Obstet Gynecol; 1984 May; 149(2):154-8. PubMed ID: 6202143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma carcinoembryonic antigen levels in ovarian cancer patients: a chart review and survey of published data.
    Stall KE; Martin EW
    J Reprod Med; 1981 Feb; 26(2):73-9. PubMed ID: 7012337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic significance of carcinoembryonic antigen determinations in patients with adenocarcinoma of the cervix.
    Kjorstad KE; Orjasaeter H
    Gynecol Oncol; 1984 Nov; 19(3):284-9. PubMed ID: 6500372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carcinoembryonic antigen in patients treated with radiation therapy for invasive squamous cell carcinoma of the uterine cervix.
    Donaldson E; Van Nagell JR; Wood EG; Pletsch Q; Goldenberg DM
    AJR Am J Roentgenol; 1976 Nov; 127(5):829-31. PubMed ID: 987709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of different serum tumor markers in gynecological malignancies.
    Paulick R; Caffier H; Horner G; Lang K; Filbry E
    Cancer Detect Prev; 1985; 8(1-2):115-20. PubMed ID: 4064031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of plasma lipid-bound sialic acid (LBSA) and carcinoembryonic antigen (CEA) in gynaecologic cancer patients.
    Tredese F; Maggino T; Salvagno L; Marchesoni D; Chizzolini M; Pattaro RF
    Eur J Gynaecol Oncol; 1985; 6(2):136-8. PubMed ID: 4029198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carcinoembryonic antigen in intraepithelial neoplasia of the uterine cervix.
    van Nagell JR; Meeker WR; Parker JC; Kashmiri R; McCollum V
    Am J Obstet Gynecol; 1976 Sep; 126(1):105-9. PubMed ID: 961735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical markers in the plasma and tumors of patients with gynecologic malignancies.
    van Nagell JR; Donaldson ES; Hanson MB; Gay EC; Pavlik EJ
    Cancer; 1981 Jul; 48(2 Suppl):495-503. PubMed ID: 6168368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carcinoembryonic antigen in patients with gynecologic malignancy.
    van Nagell JR; Meeker WR; Parker JC; Harralson JD
    Cancer; 1975 May; 35(5):1372-6. PubMed ID: 1122486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carcinoembryonic antigen (CEA) and other tumor markers in ovarian and cervical cancer.
    Malkin A; Kellen JA; Lickrish GM; Bush RS
    Cancer; 1978 Sep; 42(3 Suppl):1452-6. PubMed ID: 30536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of carcinoembryonic antigen (CEA) in patients with adenocarcinoma in colon and rectum.
    Lunde OC; Havig O
    Acta Chir Scand; 1982; 148(2):189-93. PubMed ID: 7148317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Carcinoembryonic antigen in gynecological oncology].
    Stiglmayer R
    Fortschr Med; 1978 Oct; 96(37):1843-5. PubMed ID: 700565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.